Sofinnova Partners closes oversubscribed €82M Sofinnova MD Start IV fund

European life sciences venture capital firmSofinnova Partners has closed its fourth medtech fund, Sofinnova MD Start IV,at €82 million. The oversubscribed fund will expand Sofinnova’s medtechcompany-c...